Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Overview of attention for article published in The Lancet, November 2020
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (99th percentile)
Mentioned by
- news
- 435 news outlets
- blogs
- 28 blogs
- policy
- 6 policy sources
- 2930 X users
- patent
- 11 patents
- 13 Facebook pages
- wikipedia
- 2 Wikipedia pages
- 20 Redditors
- q&a
- 2 Q&A threads
- video
- 2 YouTube creators
- podcasts
- 3 podcasts
Readers on
- mendeley
- 2047 Mendeley